Home

 

1055 Westlakes Drive

Suite 200

Berwyn, PA 19312

© 2018 Complexa. All rights reserved.

  • LinkedIn - Grey Circle

Signaling a Brighter Future for Patients with Life-Threatening Diseases

About Complexa

Complexa Inc. is a clinical stage biopharmaceutical company focused on transforming the lives of patients burdened with severe and life-threatening fibrosis and inflammatory diseases. The Company is developing medicines with the goal of preventing and repairing tissue injury and reversing fibrosis and inflammation. Our focus is on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. 

News

October 04, 2019

Complexa Receives Orphan Drug Designation from the FDA for CXA-10 in Pulmonary Arterial Hypertension

August 19, 2019

Complexa Names Theodore Danoff, MD, PhD, Chief Medical Officer

Please reload